An open-label pilot study of high-concentration capsaicin patch in painful HIV neuropathy.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Journal of Pain and Symptom Management

• Publication date

  2008-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/J.JPAINSYMMAN.2007.04.015PMID 17959343
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The international conference on harmonisation of technical requirements for registration of pharmaceuticals for human use

  2009cited by this paper
• HIV neuropathy natural history cohort study

  2006cited by this paper
• Neurological complications of HIV infection.

  2005cited by this paper
• HIV-Associated Neuropathic Pain

  2005cited by this paper
• Markers of immune activation and viral load in HIV-associated sensory neuropathy

  2005cited by this paper
• Forty years in capsaicin research for sensory pharmacology and physiology.

  2004cited by this paper
• HIV-associated distal sensory polyneuropathy in the era of highly active antiretroviral therapy: the Manhattan HIV Brain Bank.

  2004cited by this paper
• Recent developments in transient receptor potential vanilloid receptor 1 agonist-based therapies

  2004cited by this paper
• The time course of epidermal nerve fibre regeneration: studies in normal controls and in people with diabetes, with and without neuropathy.

  2004cited by this paper
• Lamotrigine for HIV-associated painful sensory neuropathies

  2003cited by this paper
• Reduced intraepidermal nerve fiber density in HIV-associated sensory neuropathy

  2002cited by this paper
• Clinical importance of changes in chronic pain intensity measured on an 11‐point numerical pain rating scale

  2001cited by this paper
• Topical capsaicin in the management of HIV-associated peripheral neuropathy.

  2000cited by this paper
• A placebo-controlled trial of lamotrigine for painful HIV-associated neuropathy

  2000cited by this paper
• Peripheral nerve function in HIV infection: clinical, electrophysiologic, and laboratory findings.

  1999cited by this paper
• The cloned capsaicin receptor integrates multiple pain-producing stimuli.

  1998cited by this paper
• Treatment of Intractable Pain with Topical Large-Dose Capsaicin: Preliminary Report

  1998cited by this paper
• A critical review of controlled clinical trials for peripheral neuropathic pain and complex regional pain syndromes

  1997cited by this paper
• The capsaicin receptor: a heat-activated ion channel in the pain pathway

  1997cited by this paper
• The effectiveness of topically applied capsaicin

  1994cited by this paper
• Neuropharmacological mechanisms of capsaicin and related substances.

  1992cited by this paper

• Topical analgesics for neuropathic pain: An Evidence-Informed guide for the practicing clinician.

  2025cites this paper
• Narrative review of the efficacy and safety of the high-concentration (179mg) capsaicin patch in peripheral neuropathic pain with recommendations for clinical practice and future research

  2025cites this paper
• Capsaicin: Emerging Pharmacological and Therapeutic Insights

  2024cites this paper
• Is the Capsaicin 179 mg (8% w/w) Cutaneous Patch an Appropriate Treatment Option for Older Patients with Peripheral Neuropathic Pain?

  2024cites this paper
• Treating neuropathic pain and comorbid affective disorders: Preclinical and clinical evidence

  2024cites this paper
• Comment on ‘chronic pain is no more prevalent in people living with HIV than in their uninfected counterparts in South Africa’ by Kamerman

  2023cites this paper
• Traditional processing increases biological activities of Dendrobium offificinale Kimura et. Migo in Southeast Yunnan, China

  2022cites this paper
• Dermatopharmacokinetic and pharmacodynamic evaluation of a novel nanostructured formulation containing capsaicinoids for treating neuropathic pain.

  2021cites this paper
• Human immunodeficiency virus–related peripheral neuropathy: A systematic review and meta‐analysis

  2020cites this paper
• Identification of the dietary supplement capsaicin as an inhibitor of Lassa virus entry

  2020cites this paper
• Sensitized vasoactive C-nociceptors: key fibers in peripheral neuropathic pain

  2019cites this paper
• Plant-derived medicines for neuropathies: a comprehensive review of clinical evidence

  2019cites this paper
• The use of biodegradable microneedle patches to increase penetration of topical steroid for prurigo nodularis

  2018cites this paper
• HIV-Related Pain Syndromes

  2018cites this paper
• The time course of brief and prolonged topical 8% capsaicin-induced desensitization in healthy volunteers evaluated by quantitative sensory testing and vasomotor imaging

  2018cites this paper
• The Role of Qutenza® (Topical Capsaicin 8%) in Treating Neuropathic Pain from Critical Ischemia in Patients with End-Stage Renal Disease: An Observational Cohort Study

  2016cites this paper
• Antinociceptive effects of topical mepivacaine in a rat model of HIV-associated peripheral neuropathic pain

  2016cites this paper
• Assessment of adverse drug reactions caused by HAART at antiretroviral clinics in the Maseru district, Lesotho

  2014cites this paper
• Cutaneous Drug Delivery of Capsaicin after in vitro Administration of the 8% Capsaicin Dermal Patch System

  2014cites this paper
• Capsaicin-based therapies for pain control.

  2014cites this paper
• Acu/Moxa for Distal Sensory Peripheral Neuropathy in HIV: A Randomized Control Pilot Study

  2013cites this paper
• Understanding and Treating Neuropathic Pain

  2013cites this paper
• NGX-4010, a Capsaicin 8% Dermal Patch, for the Treatment of Painful HIV-associated Distal Sensory Polyneuropathy: Results of a 52-Week Open-Label Study

  2013cites this paper
• Insulin-Like Growth Factor-1 Prevents Dorsal Root Ganglion Neuronal Tyrosine Kinase Receptor Expression Alterations Induced by Dideoxycytidine In Vitro

  2013cites this paper
• Positive allosteric modulation of TRPV1 as a novel analgesic mechanism

  2012cites this paper
• Tolerability of NGX-4010, a capsaicin 8% patch, in conjunction with three topical anesthetic formulations for the treatment of neuropathic pain

  2012cites this paper
• Targeting TRPV1 for pain relief: limits, losers and laurels

  2012cites this paper
• A Randomized, Double-Blind, Controlled Study of NGX-4010, a Capsaicin 8% Dermal Patch, for the Treatment of Painful HIV-Associated Distal Sensory Polyneuropathy

  2012cites this paper
• Natural Products in Drug Discovery: Impacts and Opportunities — An Assessment

  2011cites this paper
• Efficacy, safety, and tolerability of NGX-4010, capsaicin 8% patch, in an open-label study of patients with peripheral neuropathic pain.

  2011cites this paper
• Capsaicin 8% Topical Patch (Qutenza)—A Review of the Evidence

  2011cites this paper
• Postherpetic neuralgia (PHN)

  2011cites this paper
• Treatment considerations in painful HIV-related neuropathy.

  2011cites this paper
• Neural Blockade with Neurolytic Agents in the Management of Cancer Pain

  2011cites this paper
• Local Therapies for Localised Neuropathic Pain

  2011cites this paper
• Measurement and Correlation for the Solubilities of Dihydrocapsaicin in n-Heptane, n-Hexane, n-Pentane, Ethyl Acetate, Acetone, Ethanol, and Water

  2011cites this paper
• diabetic neuropathy Review : Novel insights on diagnosis , cause and treatment of diabetic neuropathy : focus on painful

  2010cites this paper
• Long-term safety of NGX-4010, a high-concentration capsaicin patch, in patients with peripheral neuropathic pain.

  2010cites this paper
• Painful HIV-Associated Sensory Neuropathy

  2010cites this paper
• HIV Infection and the PNS

  2010cites this paper
• Review: Novel insights on diagnosis, cause and treatment of diabetic neuropathy: focus on painful diabetic neuropathy

  2010cites this paper
• Acupuncture/Moxibustion RCT for Distal Sensory Peripheral Neuropathy in HIV/AIDS: Rationale, Design, Methods, Procedure and Logistics.

  2010cites this paper
• Targeting TRPV1: Challenges and Issues in Pain Management

  2010cites this paper
• Safety and Efficacy of Topical Diclofenac Sodium 1 % Gel in Seniors and Younger Patients with Hand Osteoarthritis

  2010cites this paper
• Ion channel blockers for the treatment of neuropathic pain.

  2010cites this paper
• Pharmacological Treatment of Painful HIV-Associated Sensory Neuropathy: A Systematic Review and Meta-Analysis of Randomised Controlled Trials

  2010cites this paper
• NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia: a randomized, double-blind, controlled study with an open-label extension.

  2010cites this paper
• Actualités – Brèves de DouleursRubrique sous la direction de Florentin ClèreLes topiques locaux : une voie d’avenir pour l’antalgie ?The topical applications: A way of future for the analgesia?

  2009cites this paper
• Therapeutic potential of vanilloid receptor TRPV1 agonists and antagonists as analgesics: Recent advances and setbacks.

  2009cites this paper
• NGX-4010, a high-concentration capsaicin dermal patch for lasting relief of peripheral neuropathic pain.

  2009cites this paper
• NeuroAIDS: An Evolving Epidemic

  2009cites this paper
• Distal Sensory Peripheral Neuropathy in HIV: A Case Study

  2009cites this paper
• NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia: a randomised, double-blind study.

  2008cites this paper
• Controlled trial of high-concentration capsaicin patch for treatment of painful HIV neuropathy

  2008influential citation
• Natural products to drugs: natural product-derived compounds in clinical trials.

  2005cites this paper